| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total other income | 7,788 | 2,091 | -4,981 | 1,975 |
| Net loss before tax | -17,757 | -57 | -100,991 | -37,428 |
| Income tax expense | 1,837 | 1,128 | 224 | 808 |
| Net loss | -19,594 | -1,185 | -101,215 | -38,236 |
| Increase (decrease) in net loss per share (in usd per share) | -0.1 | -0.01 | -0.54 | -0.21 |
| Net loss per sharebasic (in usd per share) | -0.1 | -0.01 | -0.54 | -0.21 |
| Weighted average common shares outstandingbasic (in shares) | 189,262,000 | 188,902,000 | 186,813,000 | 184,795,000 |
| Weighted average common shares outstandingdiluted (in shares) | 189,262,000 | 188,902,000 | 186,813,000 | 184,795,000 |
EXACT SCIENCES CORP (EXAS)
EXACT SCIENCES CORP (EXAS)